Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa van Empel

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|April 22, 2015
Inflammation in HFpEF: Key or circumstantial?Vanessa van Empel, Hans-Peter Brunner-La Rocca
European Heart Journal|July 12, 2018
Helping to understand heart failure with preserved ejection fractionVanessa van Empel, Hans-Peter Brunner-La Rocca
American Journal of Physiology. Heart and Circulatory Physiology|September 22, 2018
Targeted HFpEF therapy based on matchmaking of human and animal modelsArantxa Barandiarán Aizpurua, Blanche Schroen, Marc van Bilsen, et al.
International Journal of Cardiology|August 18, 2014
Determinants and implications of elevated soluble ST2 levels in heart failureDavid M Kaye, Justin A Mariani, Vanessa van Empel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2017
Why septal motion is a marker of right ventricular failure in pulmonary arterial hypertension: mechanistic analysis using a computer modelGeorgina Palau-Caballero, John Walmsley, Vanessa Van Empel, et al.
European Heart Journal|April 4, 2017
Just air good enough in pulmonary hypertension?Vanessa van Empel, Christian Knackstedt, Pieter van Paassen, et al.
Cardiovascular Research|February 21, 2018
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzleMonika Rech, Arantxa Barandiarán Aizpurua, Vanessa van Empel, et al.
International Journal of Cardiology|January 24, 2014
Heart failure and COPD: time to SHIFT?Sandra Sanders-van Wijk, Vanessa van Empel, Christian Knackstedt, et al.
European Journal of Heart Failure|January 13, 2018
An old debate still in the β-phase?Arantxa Barandiarán Aizpurua, Frits M E Franssen, Vanessa van Empel, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary HypertensionRachid Tobal, Judith Potjewijd, Daan van Doorn, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|April 22, 2015
Inflammation in HFpEF: Key or circumstantial?Vanessa van Empel, Hans-Peter Brunner-La Rocca
European Heart Journal|July 12, 2018
Helping to understand heart failure with preserved ejection fractionVanessa van Empel, Hans-Peter Brunner-La Rocca
American Journal of Physiology. Heart and Circulatory Physiology|September 22, 2018
Targeted HFpEF therapy based on matchmaking of human and animal modelsArantxa Barandiarán Aizpurua, Blanche Schroen, Marc van Bilsen, et al.
International Journal of Cardiology|August 18, 2014
Determinants and implications of elevated soluble ST2 levels in heart failureDavid M Kaye, Justin A Mariani, Vanessa van Empel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2017
Why septal motion is a marker of right ventricular failure in pulmonary arterial hypertension: mechanistic analysis using a computer modelGeorgina Palau-Caballero, John Walmsley, Vanessa Van Empel, et al.
European Heart Journal|April 4, 2017
Just air good enough in pulmonary hypertension?Vanessa van Empel, Christian Knackstedt, Pieter van Paassen, et al.
Cardiovascular Research|February 21, 2018
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzleMonika Rech, Arantxa Barandiarán Aizpurua, Vanessa van Empel, et al.
International Journal of Cardiology|January 24, 2014
Heart failure and COPD: time to SHIFT?Sandra Sanders-van Wijk, Vanessa van Empel, Christian Knackstedt, et al.
European Journal of Heart Failure|January 13, 2018
An old debate still in the β-phase?Arantxa Barandiarán Aizpurua, Frits M E Franssen, Vanessa van Empel, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary HypertensionRachid Tobal, Judith Potjewijd, Daan van Doorn, et al.
Pageof 6